Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Index levels influence expectations and decisions in markets. Here are core reasons they matter and how to leverage them in trading.
24,028 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Rocket Lab has surged more than 350% in a year, but investors remain split on the sustainability of the rally as back...
The SpaceX sell-off is showing signs of worsening momentum, but patient investors can still navigate it with a discip...
A blockbuster deal reshapes the media landscape and leaves Netflix with a substantial windfall. This article breaks d...
If you want exposure to AI without guessing which software will win, focus on the backbone: AI infrastructure stocks ...
GE Vernova’s stock slid after a mixed Q2 report, with earnings missing estimates but revenue beating forecasts. This ...
Flaharty Asset Management just expanded its exposure to a short-duration fixed-income strategy by buying a sizable st...
A surprise move in crypto rankings highlights the push and pull around privacy coins. This guide breaks down what zca...
Space infrastructure hurdles are shrinking as Redwire reports stronger backlog and new contracts. This week, redwire ...
Two under-the-radar oil stocks could become big movers. This guide shows how to spot overlooked stocks before they so...
As AI and automation reshape the job landscape, building passive income becomes a priority. Here are three high-yield...
A bold AI experiment in Argentina aimed at reshaping public policy stumbled on human error and bad data. The fallout ...